Basics Aquestive Therapeutics, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $399.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.74% Avg Daily Range (30 D): $0.11 | 2.99% Avg Daily Range (90 D): $0.11 | 3.51% Institutional Daily Volume Avg Daily Volume: .71M Avg Daily Volume (30 D): 1.24M Avg Daily Volume (90 D): 1.31M Trade Size Avg Trade Size (Sh.): 178 Avg Trade Size (Sh.) (30 D): 156 Avg Trade Size (Sh.) (90 D): 165 Institutional Trades Total Inst.Trades: 126 Avg Inst. Trade: $1.94M Avg Inst. Trade (30 D): $1.16M Avg Inst. Trade (90 D): $1.53M Avg Inst. Trade Volume: .5M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.17M Avg Closing Trade (30 D): $1.47M Avg Closing Trade (90 D): $1.06M Avg Closing Volume: 515.39K     News Jul 22, 2025 @ 11:00 AM Aquestive Therapeutics Names Sherry Korczynski as ... Source: Aquestive Therapeutics Apr 9, 2025 @ 11:00 AM Aquestive Therapeutics to Participate in Piper San... Source: N/A Feb 12, 2025 @ 12:00 PM Aquestive Therapeutics to Present New Findings on ... Source: N/A Jun 27, 2024 @ 12:00 PM Aquestive Therapeutics to Participate in Leerink P... Source: Aquestive Therapeutics, Inc. Jun 3, 2024 @ 12:00 PM Aquestive Therapeutics Announces Executive Appoint... Source: Aquestive Therapeutics, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.59 $-.24 $-.19 Diluted EPS $-.59 $-.24 $-.19 Revenue $ 54.23M $ 8.72M $ 11.87M Gross Profit $ 37.09M $ 5.07M $ 7.35M Net Income / Loss $ -54.24M $ -22.93M $ -17.06M Operating Income / Loss $ -41.18M $ -19.37M $ -13.58M Cost of Revenue $ 17.14M $ 3.65M $ 4.52M Net Cash Flow $ -26.54M $ -2.89M $ -6.35M PE Ratio